AzTrials
AzTrials

HIV - Human Immunodeficiency VirusNCT02571504

Cognitive Training for the Remediation of Functional Brain Health in HIV

A study testing Plasticity-based Adaptive Cognitive Remediation (PACR) in people with HIV - Human Immunodeficiency Virus and Cognitive Impairment, run by McGill University at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Cognitive deficits in HIV reflect degraded brain network functioning that may be amenable to remediation through cognitive training. In this sub-study, we will make use of Plasticity-based Adaptive Cognitive Remediation (PACR), which applies well-understood techniques derived from brain plasticity and… Read more about this study

Who is it for?
Ages 35 years and older
What is being tested?
Plasticity-based Adaptive Cognitive Remediation (PACR)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
81 participants
Where
1 siteCanada
Study dates
Apr 2015to May 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 35 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • age 35 years or older;
  • HIV infection for at least 1 year;
  • able to communicate in English or French;
  • capable of providing informed consent;
  • easy access to the internet;
  • EEG and MRI compatible

Who cannot join

  • presence of dementia;
  • life expectancy < 3 y;
  • other neurological disorder including active opportunistic CNS infection;
  • psychotic disorder;
  • current substance dependence or abuse; and
  • Hepatitis C requiring interferon therapy during the study period

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • Montreal Neurological Institute and Hospital (McGill University)

    Montreal, Quebec, H3A 2B4

Other trials in Canada

About this study

Official title: Brain Imaging to Understand HIV-associated Neurocognitive Disorder and Predict Response to Cognitive Training

Cognitive deficits in HIV reflect degraded brain network functioning that may be amenable to remediation through cognitive training. In this sub-study, we will make use of Plasticity-based Adaptive Cognitive Remediation (PACR), which applies well-understood techniques derived from brain plasticity and implicit/procedural/perceptual learning to improve the speed and accuracy of information processing, with exercises that are designed to drive generalized improvements. Simultaneously, these exercises heavily engage neuromodulatory systems to re-establish their normal control over learning and memory. As an individual restores these degraded abilities through intensive procedural learning, the encoding of naturalistic information significantly improves, and all resulting declarative memory and cognitive functions based on the quality of that incoming information necessarily improve as well, leading to improvement that generalizes beyond the trained tasks.

A subset of 80 HIV+ individuals will undergo eight weeks of PACR to determine its feasibility and appropriateness for people with mild cognitive difficulties related to HIV infection. The results of this study are expected to be pivotal in generating data to create an optimal training program aimed at stabilizing or improving brain function in HIV infected individuals experiencing cognitive decline.

Read the detailed description

The typical patterns of cognitive deficits in HIV reflect degraded brain network functioning, likely due to a combination of brain health insults: some generic (aging), some HIV-specific (inflammation, diffuse demyelination and inherent vulnerability that varies across individuals). Consistent with this view, the cognitive domains most affected are those that rely on extended networks (e.g. attention and executive functions relying on fronto-parietal and fronto-striatal circuits), exquisite timing (psychomotor function), or both. These network-based cognitive functions are vulnerable, but they are also resilient: there is a high degree of learning-dependent plasticity in networks involving the frontal lobes. This argues that the cognitive deficits in HIV may be amenable to remediation through cognitive training, and suggests mechanisms by which this might occur. There are many forms of cognitive rehabilitation; approaches that take advantage of advances in our understanding of the mechanisms of neuroplasticity and the neural systems supporting human cognition are likely to be highest yield. In this study, we will make use of Plasticity-based Adaptive Cognitive Remediation (PACR), a powerful method for harnessing this plastic potential. Conceptually, PACR applies well-understood techniques derived from brain plasticity and implicit/procedural/perceptual learning to improve the speed and accuracy of information processing, with exercises that are designed to drive generalized improvements. Simultaneously, these exercises heavily engage neuromodulatory systems to re-establish their normal control over learning and memory. As an individual restores these degraded abilities through intensive procedural learning, the encoding of naturalistic information significantly improves, and all resulting declarative memory and cognitive functions based on the quality of that incoming information necessarily improve as well, leading to improvement that generalizes beyond the trained tasks. Multiple randomized controlled studies have now demonstrated that PACR improves cognitive and functional abilities in patient populations with cognitive dysfunction similar in type and magnitude to patients with cognitive deficits due to HIV.

PACR runs in a web browser on any Internet connected computer and is implemented in an engaging game-like format. The participant selects one of the cognitive exercises scheduled for the day, and performs that exercise for fifteen minutes. The exercise itself contains the core science stimuli and task built into a game-like experience. Participants perform tens to hundreds of trials over the course of the fifteen-minute session, with each trial providing auditory and visual feedback and rewards to indicate if the trial was performed correctly or incorrectly. After each trial, the difficulty of the next trial is updated to ensure that within a session, the participant gets ~85% of trials correct. Thus, training is individually tailored to maximize its effectiveness. Summary screens including game metrics (points, levels) and exercise metrics (usage, progress) are shown to the participant at the end of each session. The scheduling mechanism ensures that a patient progresses through the exercises in a defined order, generally moving from more simple (early sensory processing) exercises to more complex (multimodal, cognitive control) exercises over the course of the 8 weeks experience. At any point in time, the participant only has access to a subset (typically six) of these exercises, four of which are performed per day.

Each exercise has specific criteria for completion, and after those criteria are met the exercise is removed from the active set and the next exercise added. This mechanism ensures both ongoing novelty and engagement for the participant, and that the participant progresses smoothly through the complete set of exercises over the program use period.

Free access will be provided to the PACR program, and a tailored cognitive training program will be developed in both French and English, specifically targeting domains and mechanisms that are most affected in HIV. This will include selection of the most suitable training modules (12 are planned), and optimization of the Web-based presentation and feedback to ensure acceptability to this target group.

The treatment goal will be use of the assigned program in 30 minutes sessions, five sessions per week, for 8 weeks after randomization; program use will be any mix of at home (or community Internet resource) or in-clinic sessions.

The outcome will be responder status (defined as improvement of >0.5 logits) on the B-CAM. With the assumption that the outcome is drawn from a binomial distribution with an expected probability of response of 10% (n=3) with no intervention, 30 subjects in the immediate training group will allow detection of a positive response at P<0.05 if 7 or more persons respond. The observed responses in both groups will provide more accurate estimates to plan for a scale up of this work to a full trial. An exploratory analysis will evaluate response in only those who completed at least 60% of the training sessions, recognizing that power here will be reduced, but the information nonetheless important.

Participants from both groups will also be compared to all those eligible for randomization to this intervention in the platform as a whole. Generalized estimating equations (GEE) will be applied as a secondary, more general approach here that permits other time points to be modeled, and consideration of other outcomes. This accommodates either binary (responder status) or continuous (scores on cognitive tests) outcomes. This analysis uses a regression model, but clustering of outcomes within time is controlled. For binary outcomes, the effect of group (immediate or control) is expressed as an odds ratio; for continuous outcomes the parameter is an effect size equivalent to an adjusted paired-t-test. An interaction term tests whether the effect differed by group (i.e. was larger in the immediate training group as hypothesized).

Additional analyses will be used to explain changes in B-CAM score as a function of changes expected from the intervention. As the intervention cohort is small, we will use concordance parameters, rather than a regression model, to quantify the degree to which changes in hypothesized mechanisms by which the interventions operate are concordant (at the individual level) with changes in the outcomes (cognitive ability).

Being tested
Plasticity-based Adaptive Cognitive Remediation (PACR)
Keywords
HIV - Human Immunodeficiency Virus, Memory, Concentration
Medical subject headings
Acquired Immunodeficiency Syndrome, Cognitive Dysfunction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Plasticity-based Adaptive Cognitive Remediation (PACR)Behavioural

    Web-based cognitive training program focused on improving attention and executive function (designed by Posit Science)

Study groups in NCT02571504
Study groupRoleWhat they receive
Immediate cognitive training groupExperimentalPlasticity-based Adaptive Cognitive Remediation (PACR) is an 8 week training to improve executive functions (e.g., working memory, flexibility, cognitive control) as well as attention. Participants in the immediate cognitive training group will receive the PACR intervention shortly after enrollment.
Receives: Behavioral: Plasticity-based Adaptive Cognitive Remediation (PACR)
Waitlist control groupExperimentalParticipants in the waitlist control group will receive a brochure with 8 simple tips for better brain health around the time of enrollment. They will begin the Plasticity-based Adaptive Cognitive Remediation (PACR) intervention within 8 weeks of the initial enrollment.
Receives: Behavioral: Plasticity-based Adaptive Cognitive Remediation (PACR)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Brief Cognitive Ability Measure (B-CAM)

    Ruler-like measure of cognitive ability combining self-report and performance items

    Measured: 3-4 months

Secondary outcomes (2)
  1. Change in Brain Health Indicators

    Questionnaire on changes in self-report brain health indicators

    Measured: 3 months

  2. Perceived Deficits Questionnaire

    Questionnaire on changes in self-report cognitive concerns

    Measured: 9 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Oct 2015 (estimated)
  2. Study startApr 2015
  3. Primary completionMay 2017
  4. Study completionMay 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
81 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02571504
Sponsor's protocol ID
14-367 BMD
Other IDs
CTNPT 026
Status last verified
Sep 2017
First submitted
25 Aug 2015
Last updated
21 Sep 2017
Results posted
No
Data monitoring committee
No
Individual data sharing
Yes: Fully anonymized individual data may be requested from the investigators.

Publications

  • Clifford DB, Ances BM. HIV-associated neurocognitive disorder. Lancet Infect Dis. 2013 Nov;13(11):976-86. doi: 10.1016/S1473-3099(13)70269-X.

    PubMed 24156898
  • Power C, Boisse L, Rourke S, Gill MJ. NeuroAIDS: an evolving epidemic. Can J Neurol Sci. 2009 May;36(3):285-95. doi: 10.1017/s0317167100007009.

    PubMed 19534327
  • Au A, Cheng C, Chan I, Leung P, Li P, Heaton RK. Subjective memory complaints, mood, and memory deficits among HIV/AIDS patients in Hong Kong. J Clin Exp Neuropsychol. 2008 Apr;30(3):338-48. doi: 10.1080/13803390701416189. Epub 2007 Jul 25.

    PubMed 17852611
  • Holt JL, Kraft-Terry SD, Chang L. Neuroimaging studies of the aging HIV-1-infected brain. J Neurovirol. 2012 Aug;18(4):291-302. doi: 10.1007/s13365-012-0114-1. Epub 2012 Jun 1.

    PubMed 22653528
  • Vinogradov S, Fisher M, de Villers-Sidani E. Cognitive training for impaired neural systems in neuropsychiatric illness. Neuropsychopharmacology. 2012 Jan;37(1):43-76. doi: 10.1038/npp.2011.251. Epub 2011 Nov 2.

    PubMed 22048465
  • Mahncke HW, Bronstone A, Merzenich MM. Brain plasticity and functional losses in the aged: scientific bases for a novel intervention. Prog Brain Res. 2006;157:81-109. doi: 10.1016/S0079-6123(06)57006-2.

    PubMed 17046669
  • Fisher M, Holland C, Merzenich MM, Vinogradov S. Using neuroplasticity-based auditory training to improve verbal memory in schizophrenia. Am J Psychiatry. 2009 Jul;166(7):805-11. doi: 10.1176/appi.ajp.2009.08050757. Epub 2009 May 15.

    PubMed 19448187
  • Mahncke HW, Connor BB, Appelman J, Ahsanuddin ON, Hardy JL, Wood RA, Joyce NM, Boniske T, Atkins SM, Merzenich MM. Memory enhancement in healthy older adults using a brain plasticity-based training program: a randomized, controlled study. Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12523-8. doi: 10.1073/pnas.0605194103. Epub 2006 Aug 3.

    PubMed 16888038
  • Zelinski EM, Spina LM, Yaffe K, Ruff R, Kennison RF, Mahncke HW, Smith GE. Improvement in memory with plasticity-based adaptive cognitive training: results of the 3-month follow-up. J Am Geriatr Soc. 2011 Feb;59(2):258-65. doi: 10.1111/j.1532-5415.2010.03277.x.

    PubMed 21314646
  • Ances BM, Ortega M, Vaida F, Heaps J, Paul R. Independent effects of HIV, aging, and HAART on brain volumetric measures. J Acquir Immune Defic Syndr. 2012 Apr 15;59(5):469-77. doi: 10.1097/QAI.0b013e318249db17.

    PubMed 22269799
  • Tate DF, Conley J, Paul RH, Coop K, Zhang S, Zhou W, Laidlaw DH, Taylor LE, Flanigan T, Navia B, Cohen R, Tashima K. Quantitative diffusion tensor imaging tractography metrics are associated with cognitive performance among HIV-infected patients. Brain Imaging Behav. 2010 Mar;4(1):68-79. doi: 10.1007/s11682-009-9086-z. Epub 2010 Jan 19.

    PubMed 20503115
  • Du H, Wu Y, Ochs R, Edelman RR, Epstein LG, McArthur J, Ragin AB. A comparative evaluation of quantitative neuroimaging measurements of brain status in HIV infection. Psychiatry Res. 2012 Jul 30;203(1):95-9. doi: 10.1016/j.pscychresns.2011.08.014. Epub 2012 Aug 12.

    PubMed 22892348
  • Eskildsen SF, Coupe P, Garcia-Lorenzo D, Fonov V, Pruessner JC, Collins DL; Alzheimer's Disease Neuroimaging Initiative. Prediction of Alzheimer's disease in subjects with mild cognitive impairment from the ADNI cohort using patterns of cortical thinning. Neuroimage. 2013 Jan 15;65:511-21. doi: 10.1016/j.neuroimage.2012.09.058. Epub 2012 Oct 2.

    PubMed 23036450
  • Coupe P, Manjon JV, Fonov V, Pruessner J, Robles M, Collins DL. Patch-based segmentation using expert priors: application to hippocampus and ventricle segmentation. Neuroimage. 2011 Jan 15;54(2):940-54. doi: 10.1016/j.neuroimage.2010.09.018. Epub 2010 Sep 17.

    PubMed 20851199
  • Coupe P, Eskildsen SF, Manjon JV, Fonov VS, Collins DL; Alzheimer's disease Neuroimaging Initiative. Simultaneous segmentation and grading of anatomical structures for patient's classification: application to Alzheimer's disease. Neuroimage. 2012 Feb 15;59(4):3736-47. doi: 10.1016/j.neuroimage.2011.10.080. Epub 2011 Nov 9.

    PubMed 22094645

Questions about this trial

What is this clinical trial studying?

A study testing Plasticity-based Adaptive Cognitive Remediation (PACR) in people with HIV - Human Immunodeficiency Virus and Cognitive Impairment, run by McGill University at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Sep 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Brief Cognitive Ability Measure (B-CAM) (time frame: 3-4 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02571504, which also lists 43 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Sep 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in